156 related articles for article (PubMed ID: 3895033)
21. Bromocriptine treatment in Parkinson's disease.
Parkes JD; Marsden CD; Donaldson I; Galea-Debono A; Walters J; Kennedy G; Asselman P
J Neurol Neurosurg Psychiatry; 1976 Feb; 39(2):184-93. PubMed ID: 772175
[TBL] [Abstract][Full Text] [Related]
22. Comparison of pergolide and bromocriptine therapy in parkinsonism.
LeWitt PA; Ward CD; Larsen TA; Raphaelson MI; Newman RP; Foster N; Dambrosia JM; Calne DB
Neurology; 1983 Aug; 33(8):1009-14. PubMed ID: 6348585
[TBL] [Abstract][Full Text] [Related]
23. Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease.
McElvaney NG; Wilcox PG; Churg A; Fleetham JA
Arch Intern Med; 1988 Oct; 148(10):2231-6. PubMed ID: 3178380
[TBL] [Abstract][Full Text] [Related]
24. Treatment of Parkinson's disease with 8-alpha-amino-ergoline, CU 32-085.
Schneider E; Hubener K; Fischer PA
Neurology; 1983 Apr; 33(4):468-72. PubMed ID: 6682193
[TBL] [Abstract][Full Text] [Related]
25. Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study.
Staal-Schreinemachers AL; Wesseling H; Kamphuis DJ; vd Burg W; Lakke JP
Neurology; 1986 Feb; 36(2):291-3. PubMed ID: 3511405
[TBL] [Abstract][Full Text] [Related]
26. Long-term use of dopamine agonists in Parkinson's disease.
Jankovic J
Clin Neuropharmacol; 1985; 8(2):131-40. PubMed ID: 3891082
[No Abstract] [Full Text] [Related]
27. [Bromocriptine and Parkinson's disease: initial results].
Petit H; Destee A
Lille Med; 1977; 22(6):362-5. PubMed ID: 578286
[No Abstract] [Full Text] [Related]
28. Studies with bromocriptine. Part 1. "On-off" phenomena.
Kartznel R; Calne DB
Neurology; 1976 Jun; 26(6 PT 1):508-10. PubMed ID: 945489
[TBL] [Abstract][Full Text] [Related]
29. Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine".
Lang AE
Can J Neurol Sci; 1987 Aug; 14(3 Suppl):474-82. PubMed ID: 3315148
[TBL] [Abstract][Full Text] [Related]
30. Psychiatric effects of bromocriptine and lergotrile in Parkinsonian patients.
Serby M; Angrist B; Lieberman A
Adv Biochem Psychopharmacol; 1980; 23():287-92. PubMed ID: 6104908
[No Abstract] [Full Text] [Related]
31. Comparative efficacy of pergolide and bromocriptine in patients with advanced Parkinson's disease.
Lieberman AN; Neophytides A; Leibowitz M; Gopinathan G; Pact V; Walker R; Goodgold A; Goldstein M
Adv Neurol; 1983; 37():95-108. PubMed ID: 6858782
[TBL] [Abstract][Full Text] [Related]
32. A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results.
Riopelle RJ; Gawel MJ; Libman I; King DB; McLean DR; Paulseth R; Raphy B; Bouchard S
Eur Neurol; 1988; 28 Suppl 1():11-4. PubMed ID: 3288477
[TBL] [Abstract][Full Text] [Related]
33. [Clinical experience with bromocriptine, a central dopaminergic stimulator].
Ludin HP; Kunz F; Lörincz P; Ringwald E
Nervenarzt; 1976 Nov; 47(11):651-5. PubMed ID: 794749
[No Abstract] [Full Text] [Related]
34. Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease.
Serby M; Angrist B; Lieberman A
Am J Psychiatry; 1978 Oct; 135(10):1227-9. PubMed ID: 29497
[No Abstract] [Full Text] [Related]
35. Treatment of Parkinson's disease with bromocriptine.
Jotkowitz S
N Engl J Med; 1977 Sep; 297(9):508-9. PubMed ID: 578000
[No Abstract] [Full Text] [Related]
36. Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.
Guttman M
Neurology; 1997 Oct; 49(4):1060-5. PubMed ID: 9339690
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of parkinsonian syndromes by bromocriptin].
Gautier JC; Durand JP
Nouv Presse Med; 1977 Jan; 6(3):171-4. PubMed ID: 319421
[TBL] [Abstract][Full Text] [Related]
38. Comparison between lergotrile and bromocriptine in parkinsonism.
Teychenne PF; Pfeiffer RF; Bern SM; McInturff D; Calne DB
Ann Neurol; 1978 Apr; 3(4):319-24. PubMed ID: 666273
[TBL] [Abstract][Full Text] [Related]
39. Bromocriptine in the treatment of parkinsonism.
Parkes JD
Drugs; 1979 May; 17(5):365-82. PubMed ID: 37066
[TBL] [Abstract][Full Text] [Related]
40. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
Gawel M; Riopelle R; Libman I; Bouchard S
Adv Neurol; 1987; 45():535-8. PubMed ID: 3548263
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
